Cited by 48Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

Neuropathology of frontotemporal lobar degeneration: A review

Open access
Bahia, Valéria Santoro, Takada, Leonel Tadao, Deramecourt, Vincent·2013·Dementia & Neuropsychologia

Abstract

ABSTRACT Frontotemporal lobar degeneration (FTLD) is the second most common cause of presenile dementia. Three main clinical variants are widely recognized within the FTLD spectrum: the behavioural variant of frontotemporal dementia (bvFTD), semantic dementia (SD) and progressive non-fluent aphasia (PNFA). FTLD represents a highly heterogeneous group of neurodegenerative disorders which are best classified according to the main protein component of pathological neuronal and glial inclusions. The most common pathological class of FTLD is associated with the TDP-43 protein (FTLD-TDP), while FTLD-Tau is considered slightly less common while the FTLD-FUS (Fused in sarcoma protein) pathology is rare. In this review, these three major pathological types of FTLD are discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1590/s1980-57642013dn70100004

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 79 · Cited by 48

Research works printed but not linked: 70

  1. [1]Ratnavalli E Brayne C Dawson K Hodges JR The prevalence of frontotemporal dementia Neurology 2002 58 1615 1621 12058088
  2. [2]Johnson JK Dichl J Mendez MF Frontotemporal lobar degeneration Demographic characteristics of 353 patients. Arch Neurol 2005 62 925 930 15956163
  3. [3]Rosso SM Kaat LD Baks T Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study Brain 2003 126 2016 2022 12876142
  4. [4]Harvey RJ Skelton-Robinson M Rossor MN The prevalence and causes of dementia in people under the age of 65 years J Neurol Neurosurg Psychiatry 2003 74 1206 1209 12933919 PMC1738690
  5. [6]Neary D Snowden JS Gustafson L Frontotemporal lobar degeneration A consensus on clinical diagnostic criteria. Neurology. 1998 51 1546 1554 9855500
  6. [7]Lomen-Hoerth C Anderson T Miller B The overlap of amyotrophic lateral sclerosis and frontotemporal dementia Neurology 2002 59 1077 1079 12370467
  7. [8]Rascovsky K Hodges JR Knopman D Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia Brain 2011 1 22 21810890 PMC3170532
  8. [9]Mesulan MM Primary Progressive Aphasia Ann Neurol 2001 49 425 432 11310619
  9. [10]Mesulan MM Primary Progressive Aphasia: a language based dementia N Engl J Med 2003 349 1535 1542 14561797
  10. [11]Gorno-Tempini ML Hillis AE Weintraub S Classification of primary progressive aphasia and its variants Neurology 2011 76 1006 1014 21325651 PMC3059138
  11. [12]Rohrer JD Lashley T Schott JM Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration Brain 2011 134 2565 2581 21908872 PMC3170537
  12. [13]Scarpini E Galimberti D Clinical phenotypes and genetic biomarkers of FTLD J Neural Transm 2012 119 851 860 22527778
  13. [14]Broe M Hodges JR Schofield E Staging disease severity in pathologically confirmed cases of frontotemporal dementia Neurology 2003 60 1005 1011 12654969
  14. [15]Josephs KA Hodges JR Snowden JS Neuropathological background of phenotypical variability in frontotemporal dementia Acta neuropathol 2011 122 137 153 21614463 PMC3232515
  15. [16]Hutton N Lendon CL Rizzu P Association of missense and 5'-splice-site mutations in TAU with the inherited dementia FTDP-17 Nature 1998 393 702 705 9641683
  16. [17]Arai T Hasegawa M Akiyama H TDP-43 is a component of ubiquitin -positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Biochem Biophys Res Commun 2006 351 602 611 17084815
  17. [18]Neumann M Sampathu DM Kwong LK Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 2006 314 130 133 17023659
  18. [19]Kwiatkowski TJ Jr Bosco DA Leclerc AL Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis Science 2009 323 1205 8 19251627
  19. [20]Munoz DG Dickson DW Bergeron C The neuropathology and biochemistry of frontotemporal dementia Ann Neurol 2003 54 S24 S28 12833365
  20. [21]Dickson DW Kouri N Murray ME Josephs KA Neuropathology of frontotemporal lobar degeneration-tau (FTLD-TAU) J Mol Neurosci 2011 45 384 389 21720721 PMC3208128
  21. [22]Bigio EH TDP-43 variants of frontotemporal lobar degeneration J Mol Neurosci 2011 45 390 401 21607722 PMC3202017
  22. [23]Boxer AL Gold M Huey E Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development Alzheimers Dement 2012 S1552-5260 12 01750 01755 PMC3542408 23043900
  23. [24]Weintraub S Mesulam M With or without FUS, it is the anatomy that dictates the dementia phenotype Brain 2009 132 2906 2908 19861505 PMC2915502
  24. [25]Kim EJ Sidhu M Gaus SE Selective frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia Cereb Cortex 2012 22 251 259 21653702 PMC3256403
  25. [26]Goedert M Spillantini MG Potier MC Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain Embo J 1989 8 393 399 2498079 PMC400819
  26. [27]Goedert M Spillantini MG Pathogenesis of the tauopathies J Mol Neurosci 2011 45 425 431 21785996
  27. [28]Hong M Zhukareva V Vogelsberg-Ragaglia V Mutation specific functional impairments in distinct tau isoforms of hereditary FTDP-17 Science 1998 282 1914 1917 9836646
  28. [29]Deramecourt V Lebert F Maurage CA Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S J Alzheimers Dis 2012 31 741 749 22699846
  29. [30]Cruts M Theuns J Van Broeckhoven C Locus-specific mutation databases for neurodegenerative brain diseases Human Mutation 2012 33 1340 1344 22581678 PMC3465795
  30. [31]Cohn-Hokke PE Elting MW Pijnenburg YA van Swieten JC Genetics of dementia: update and guidelines for the clinician Am J Med Genet B Neuropsychiatr Genet 2012 159B 628 643 22815225
  31. [32]Rosso SM van Swieten JC New developments in frontotemporal dementia and parkinsonism linked to chromosome 17 Curr Opin Neurol 2002 15 423 428 12151838
  32. [33]Cairns NJ Lee VM Trojanowski JQ The cytoskeleton in neurodegenerative diseases J Pathol 2004 204 438 449 15495240 PMC3011821
  33. [34]Cairns NJ Bigio EH Mackenzie IR Consortium for Frontotemporal Lobar Degeneration Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007 114 5 22 PMC2827877 17579875
  34. [35]Mackenzie IR Neumann M Bigio EH Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update Acta Neuropathol 2010 119 1 4 19924424 PMC2799633
  35. [37]Deramecourt V Lebert F Debachy B Prediction of pathology in primary progressive language and speech disorders. Neurology 2010 74 42 49 19940270
  36. [38]Piguet O Halliday GH Reid WGJ Clinical phenotypes in autopsyconfirmed Pick disease Neurology 2011 76 253 259 21242493
  37. [39]Kouri N Whitwell JL Josephs KA Rademakers R Dickson DW Corticobasal degeneration: a pathologically distinct 4R tauopathy Nat Rev Neurol. 2011 7 263 272 21487420 PMC10006729
  38. [40]Buée L Delacourte A Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease Brain Pathol 1999 9 681 693 10517507 PMC8098140
  39. [41]Ikeda K Clinical aspects of dementia with argyrophilic grains Handb Clin Neurol 2008 89 549 552 18631776
  40. [42]Pham CT de Silva R Haïk S Tau-positive grains are constant in centenarians' hippocampus Neurobiol Aging 2011 32 1296 303 19695742
  41. [43]Tolnay M Probst A Argyrophilic grain disease Handb Clin Neurol. 2008 89 553 563 18631777
  42. [44]Josephs KA Whitwell JL Parisi JE Knopman DS Argyrophilic grains: a distinct disease or an additive pathology? Neurobiol Aging 2008 29 566 573 17188783 PMC2727715
  43. [45]Ahmed Z Doherty KM Silveira-Moriyama L Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies Acta Neuropathol. 2011 122 415 428 21773886
  44. [46]Knopman DS Overview of dementia lacking distinctive histology: pathological designation of a progressive dementia Dementia 1993 4 132 136 8401780
  45. [47]Josephs KA Holton JL Rossor MN Frontotemporal Lobar Degeneration and ubiquitin immunohistochemistry Neuropathol Appl Neurobiol 2004 30 369 373 15305982
  46. [48]Harper JW Tan MK Ubiquitin pathway proteomics Mol Cell Proteomics 2012 11 1541 1650 22962057 PMC3518111
  47. [50]Cruts M Gijselinck I Van Der Zee J Null mutations in progranulin Dement Neuropsychol 2013 3 7 1 19 26 26 Neuropathology of frontotemporal lobar degeneration Bahia VS, et al.cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006;442:920-924.
  48. [51]Buratti E Baralle FE Multiple roles of the TDP-43 in gene expression, splicing regulation, and human disease Front Biosci 2008 13 867 878 17981595
  49. [52]Sleegers K Cruts M Van Broeckhoven C Molecular pathways of frontotemporal lobar degeneration Annu Rev Neurosci 2010 33 71 88 20415586
  50. [53]Rabinovici GD Miller BL Frontotemporal Lobar degeneration. Epidemiology, pathophysiology, diagnosis and management CNS Drugs 2010 24 375 398 20369906 PMC2916644
  51. [54]Dickson DW TDP-43 immunoreactivity in neurodegenerative disorders: disease versus mechanism specificity Acta Neuropathol 2008 115 147 149 18034349 PMC2688830
  52. [55]Kumar-Singh S Progranulin and TDP-43: mechanistic links and future directions J Mol Neurosc 2011 45 561 573 PMC3207122 21863317
  53. [56]Mackenzie IR Neumann M Bigio EH Nomenclature for neuropathological subtypes of frototemporal lobar degeneration: consensus recommendations Acta Neuropathol 2006 117 15 18 PMC2710877 19015862
  54. [57]Sampathu DM Neumann M Kwong LK Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immune-histochemistry and novel monoclonal antibodies Am J Pathol 2006 169 1343 1352 17003490 PMC1780184
  55. [58]Mackenzie IR Neumann M Barborie A A harmonized classification system for FTLD-TDP pathology Acta Neuropathol 2011 122 111 113 21644037 PMC3285143
  56. [59]Tsuji H Arai T Kametani F Molecular analysis and biochemical classification of TDP-43 proteinopathy Brain 2012 135 3380 3391 23035040
  57. [60]Strong MJ Yang W The frontemporal syndromes of ALS. Clicopathological correlates J Mol Neurosci 2011 45 648 655 21809041
  58. [61]Borroni B Bonvicini C Alberici A Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease Hum Mutat 2009 30 E974 E983 19655382
  59. [62]Borroni B Archetti S Del Bo R TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course Rejuvenation Res 2010 13 509 517 20645878
  60. [63]Renton AE Majounie E Waite A A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD Neuron 2011 72 257 68 21944779 PMC3200438
  61. [64]Vance C Rogelj B Hortobagyi T Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 Science 2009 323 1208 1211 19251628 PMC4516382
  62. [65]Munoz DG Neumann M Kusaka H FUS pathology in basophilic inclusion body disease Acta Neuropathol 2009 118 617 627 19830439
  63. [66]Neumann M Rademakers R Roeber S Baker M Kretzschmar HA Mackenzie IR A new subtype of frontotemporal lobar degeneration with FUS pathology Brain 2009 132 2922 2931 19674978 PMC2768659
  64. [67]Neumann M Roeber S Kretzschmar HA Rademakers R Baker M Mackenzie IR Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease Acta Neuropathol 2009 118 605 616 19669651 PMC2864784
  65. [68]Snowden JS Hu Q Rollinson S The most common type of FTLDFUS (FTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene Acta neuropathol 2011 122 99 110 21424531
  66. [70]Lashley T Rohrer JD Bandopadhyay R A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies Brain 2011 134 2548 2564 21752791 PMC3170529
  67. [71]McKhann GM Albert MS Grossman M Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's disease Arch Neurol 2001 58 1803 1809 11708987
  68. [72]Loy CT cusker Kril JJ Very early-onset frontotemporal dementia with no family history predicts underlying fused in sarcoma pathology Brain 2010 133 e158 20693541
  69. [73]Langenhove T van der Zee J Sleegers K Genetic contribution of FUS to frontotemporal lobar degeneration Neurology 2010 74 366 371 20124201
  70. [74]Mackenzie IR Neumann M Cairns NJ Munoz DG Isaacs AM Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43 J Mol Neurosci 2011 45 402 408 21603977

Authors
Bahia, V. S., Takada, L. T., & Deramecourt, V.
Affiliations
  • Universidade de São Paulo (BR)
  • Université Lille Nord de France (FR)
Corresponding author
Bahia, Valéria Santoro
Venue
Dementia & Neuropsychologia
Published
2013-03
Volume
7
Issue
1
Pages
19-26
ISSN
1980-5764 (ISSN-L)
OpenAlex
W1562489172
Cited by
48
References
79
Citations by year
2026: 5 · 2025: 7 · 2024: 12 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 7 · 2019: 3 · 2018: 1 · 2016: 1
FWCI
0.05
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Dementia & Neuropsychologia (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • Americanae (AECID Library) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Redalyc (Universidad Autónoma del Estado de México) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
frontotemporal lobar degeneration, behavioral variant frontotemporal dementia, semantic dementia, progressive nonfluent aphasia, TDP-43, FTLD-tau, FUS, neurodegeneration, proteinopathies, glial inclusions, early-onset dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review